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In this paper, we describe a thiol-mediated and energy-dependent membrane transport of 
selenium by erythroid anion exchanger 1 (AE1, also known as band 3 protein).  The AE1 is 
the most abundant integral protein of red cell membranes and plays a critical role in the 
carbon dioxide transport system in which carbon dioxide is carried as bicarbonate in the 
plasma.  This protein mediates the membrane transport of selenium, an essential antioxidant 
micronutrient, from red cells to the plasma in a manner that is distinct from the already known 
anion exchange mechanism.  In this pathway, selenium bound to the cysteine 93 of the 
hemoglobin β chain (Hb-Cysβ93) is transported by the relay mechanism to the Cys317 of the 
amino-terminal cytoplasmic domain of the AE1 on the basis of the intrinsic interaction 
between the two proteins and is subsequently exported to the plasma via the Cys843 of the 
membrane-spanning domain.  The selenium export did not occur in plain isotonic buffer 
solutions and required thiols, such as albumin, in the outer medium.  Such a membrane 
transport mechanism would also participate in the export pathways of the nitric oxide 
vasodilator activity and other thiol-reactive substances bound to the Hb-Cysβ93 from red 
cells to the plasma and/or peripherals.   
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Introduction 
Selenium belongs to chalcogens that shares similar chemical properties especially with sulfur 
and, to a lesser extent, with tellurium.  This element is an essential micronutrient for humans 
and other higher animal species.1  Selenocysteine (SeCys), the 21st naturally occurring 
amino acid encoded by the UGA codon, is the form of selenium present in enzymes and 
proteins.  In humans, 25 SeCys-containing proteins (selenoproteins) are identified on the 
basis of their selenoproteome analysis.2  The best-known selenoproteins are the glutathione 
peroxidases (GPxs) that can catalyze the reduction of certain peroxide species (R−OOH) to 
the alcohols (R−OH) at their active center SeCys residue.1,3   
Nutritional selenium is thought to be obtained from a variety of selenium compounds in 
the diet, mostly in organic forms, such as SeCys and selenomethionine (SeMet).  During the 
systemic delivery of selenium, selenoprotein P that is present in the plasma is thought to be 
the selenium supply protein for the biosynthesis of the other selenoproteins including GPxs.4,5  
Recent evidence in selenoprotein P (SelP) knockout mice has shown that the distribution of 
selenium from the liver to testis and brain is mediated by Sel P.6,7  It is also found that in the 
absence of SelP, selenium from selenious acid (SA, H2SeO3) in the diet can be distributed to 
the peripherals by a yet unknown mechanism.8  So far, little is known about the membrane 
transport of selenium from selenium source compounds, including SA.  Inorganic SA is rare 
as a chemical form of the food source compounds, but highly bioavailable SA is most 
frequently used as a source compound for the treatment of a selenium deficiency.9  
Selenium-enriched yeast (a common form of selenium supplement) is found to contain 
significant amounts of SA.10,11  SA is also used to supplement infant formula and other 
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products.12,13  Thus, a better understanding of the systemic delivery mechanisms of selenium 
from SA is of significance from the viewpoints of medical treatments and toxicology.  In the 
bloodstream, SA is immediately taken up from the plasma into the red cell through the band 3 
protein (anion exchanger 1, AE1)14 and then returned to the plasma after reductive metabolism 
in the red cells.15–17   
AE1 is the most abundant integral protein of the red cell membrane, constituting 
~25–30 % of the total protein mass in the purified membrane, with approximately 106 copies 
present per cell.18  The AE1 is a 911-amino acid-long glycoprotein (molecular mass ~95 
kDa) involving structurally distinct domains, that is, a large amino-terminal cytoplasmic 
domain (N-CPD, Met1–Pro403), a membrane-spanning domain (MSD, Gln404−Glu882) 
containing a single N-linked glycosylation site, Asn642, on its extracellular surface and a 
short carboxyl-terminal cytoplasmic domain (C-CPD, Leu883−Val911).19−21  In the native 
membrane, the AE1 is known to be present at 60 % in dimeric and 40 % in tetrameric forms 
and forms a macrocomplex with other integral proteins and cytoskeletal proteins.22 
The AE1 plays a critical role in the carbon dioxide transport system in which carbon 
dioxide is carried as bicarbonate in the blood plasma.  Because the solubility of carbon 
dioxide in the blood plasma is rather low, the carbon dioxide molecule that diffuses into the 
red cell is converted into the bicarbonate anion by cytosolic carbonic anhydrase.  The 
bicarbonate anion is then transported out of the red cell by the AE1 during the exchange with 
a chloride anion (Cl–/HCO3– anion exchange).  The MSD mediates the anion exchange, 
while the C-CPD contains acidic motifs that constitute a core binding site for cytoplasmic 
carbonic anhydrase II9 and is required for the Cl–/HCO3– exchange process.23,24  The extreme 
sequence of the N-CPD binds multiple glycolytic enzymes25 and hemoglobin (Hb).26  Other 
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parts of this domain also provide binding sites for the cytoskeletal proteins ankryin,27 protein 
4.128 and protein 4.2.29  A major function of the N-CPD is thought to anchor the membrane to 
the underlying cytoskeleton, which is important for organizing the structure of the membrane 
and its attachment to the cytoskeleton.  The AE1 protein also constitutes the major glucose 
transporter of human erythrocytes and is probably a multifunctional transport protein 
responsible for the transport of glucose, anions, and water.30   
The AE1 contains five cysteine residues: Cys201 and Cys317 in the N-CPD, Cys479 and 
Cys843 in the MSD, and Cys885 in the C-CPD.31  Casey et al. mutated each of these 
cysteines to serine to examine their role in the function of the AE1 and stated that the cysteine 
residues of the human AE1 are not required for the anion exchange and cytoskeletal binding 
roles of the protein,32 although the membrane domain can mediate anion transport even after 
the removal of the N-CPD.33,34  The N-CPD are known to possess an intrinsic binding 
affinity for the Hb and to undergo the formation of intermolecular disulfide bonds between 
the Cys201 and/or the Cys317 and the Cysβ93 of Hb under certain conditions.35  Recently, 
Stamler and his colleagues reported that an export function of nitric oxide (NO) vasodilator 
activity from red cells to the plasma and/or the peripherals is involved in the transport of NO 
bound to the Cysβ93 of Hb to thiols of the N-CPD (Hb-Cysβ93-SNO + N-CPD-Cys-SH → 
Hb-Cysβ93-SH + N-CPD-Cys-SNO).36,37  Such NO transport could possibly be effected by 
the direct transfer of NO from one thiol to another without the generation of free NO via an 
intermediate R-S-N(O)-S-R species.38  However, molecular details of the subsequent NO 
membrane transport mediated by AE1 have not yet been verified.   
After the immediate uptake by the anion exchange function of the AE1 into red cells,14 
SA is reductively metabolized by glutathione to transform selenotrisulfide (R-SSeS-R), and is 
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then bound to the Cysβ93 of Hb by thiol exchange (Hb-Cysβ93-SSeS-R).  Selenium bound 
to the Hb is subsequently transferred to thiols of the N-CPD in a similar manner to NO.  The 
selenium export to the plasma across the membranes occurs in an oxygen-linked fashion; it is 
enhanced by increasing the proportion of the deoxygenated Hb with a higher binding affinity 
for the N-CPD than the oxygenated Hb, similar to the NO export fashion.39  Chemical 
modification of thiols in both the N-CPD and the MSD of the AE1 results in complete 
inhibition of the selenium export from red cells.40  In the present study, we investigated the 
selenium transport mechanism across red cell membranes from Hb to the plasma and 
proposed a possible mechanism for a thiol-mediated membrane transport of selenium by the 
erythroid AE1 protein.   
Experimental 
Determination of membrane protein and selenium concentrations   
The protein concentrations were colorimetrically determined by a bicinchoninic acid protein 
assay using bovine serum albumin as the reference.  2,2’-Bicinchoninic acid and Cu(II) 
sulfate were added to the red cell membrane samples dissolved in a 5 mM sodium phosphate 
solution (pH 8, 5P8) containing 1 % sodium dodecyl sulfate (SDS).  The mixtures were then 
allowed to react at 60 °C for 30 min.  The produced color was monitored at 562 nm. 
The selenium concentrations in the specimens were fluorometrically determined using 
2,3-diaminonaphthalene (DAN, Tokyo Chemical Industry Co., Ltd.) after acid digestion with 
a 1 : 5 mixture by volume of perchloric acid and nitric acid.41  The selenium standard 
solution [1000 ppm as selenium (IV) dioxide in 0.5 M nitric acid] for the fluorometry was 
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obtained from Kanto Chemical Co., Inc. 
Selenium export experiments from red cells 
Fresh human venous blood was collected in a heparinized VENOJECT II tube (TERUMO).  
Each sample was centrifuged at 1400 g for 10 min at room temperature, and the plasma, buffy 
coat and upper 10 % of the red cell layers were removed by aspiration.  The precipitated red 
cells were washed three times with 66 mM phosphate buffer [285 milliosmols (isotonic), pH 
7.4].  The purified red cells were incubated with selenious acid (SA, 8 μM, Kanto Chemical 
Co., Inc.) in the isotonic phosphate buffer (pH 7.4) and washed thoroughly with the same 
buffer.  The SA-treated red cell precipitate was combined with an equal volume of human 
blood plasma, and the mixture was incubated in a water bath with shaking at 60 min−1.  
Aliquots were withdrawn from the mixture at appropriate time intervals.  After 
centrifugation at 1400 g for 10 min at 4 ºC to separate the red cells from the plasma, the 
selenium contents in the red cells and the plasma were determined by the DAN method 
subsequent to acid digestion.  The selenium content in the red cell precipitates before mixing 
with the plasma (3.1 ± 0.1 μg mL−1-red cell) was defined as 100 %.  All blood samples were 
obtained from male healthy individuals according to the guidelines of the Ethics Committee 
of Nagasaki University. 
Isolation of red cell ghost membranes   
Unsealed red cell membranes were prepared according to the method of Steck and Kant.42  
Isolated red cells were osmotically hemolyzed by the addition of cold 5P8.  The hemolysate 
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was centrifuged at 20,000 g and 4 °C for 20 min and then the supernatant was removed by 
aspiration.  To remove hemoglobin bound to the membranes, the red pellets were washed 
thoroughly with 5P8 till the red-colored pellets become white.   
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and 
immunoblotting analyses.   
The crude membrane protein was dissolved in a mixture of 1% SDS, 0.01 M 
tris(hydroxymethyl)aminomethane-HCl (pH 8) and 10 % sucrose.  The membrane protein 
samples (20–40 μg) were electrophoresed on a 7.5 % polyacrylamide disk gel with an 
electrophoresis buffer [0.1 % SDS, 25 mM tris(hydroxymethyl)aminomethane and 192 mM 
glycine] using a pageRun AE-6531M (ATTO Corporation).  The gel electrophoresis was 
carried out under a non-reducing condition.  The molecular mass calibration was carried out 
using Precision Plus Protein standards that contain ten bands of 10–250 kDa (Bio-Rad 
Laboratories).  The locations of the proteins in the gels were determined using 0.1 % 
Coomassie blue in 30 % methanol-acetic acid mixed solution).  For the immunoblotting 
analysis, the membrane proteins on the gels were transferred onto a P membrane (polyvinyl 
difluoride membrane, ATTO Corporation).  The membrane samples were blocked with 1 % 
nonfat milk in 0.1 % Tween-20 supplemented 25 mM tris(hydroxymethyl)aminomethane- 
HCl-buffered saline.  The mouse monoclonal anti-human AE1 antibody, that is directed 
against within 20 kDa from the amino-terminal domain, (Alpha Diagnostic Int’l, Inc.) at a 
1:3,000 dilution was then applied, followed by goat antimouse antibody-horseradish 
peroxidase conjugate (Alpha Diagnostic Int’l, Inc.) at a 1 : 17,500 dilution.  An LAS-1000 
luminescent image analyzer (Fujifilm Co.) was used to detect the AE1 immunoblot. 
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Fractionation of red cell membrane proteins   
Isolated red cell membranes were fractionated as previously described with slight 
modification.40  To remove N-CPD from the membranes, selenium-bound membranes were 
first digested with 20 μg mL−1 α-chymotrypsin (α-Chy, from bovine pancreas, 35–65 units 
mg−1, Nacalai Tesque, Inc.) in 5P8 at 37 °C for 10 min and centrifuged at 20,000 g and 4 °C 
for 20 min [fraction (i)].  The α-Chy-treated membranes were subsequently incubated with 
0.1 M NaOH for 30 min on ice to remove peripheral proteins and washed three times with a 
cold 5P8 [fraction (ii)].  To separate C-CPD from the membranes, the membranes were 
further digested with 25 μg mL−1 trypsin [Try, from porcine pancreas, 1,000–2,000 units mg−1, 
salt free, Nacalai Tesque, Inc.] in 5P8 for 1 h at 37 °C [fraction (iii)].   
Matrix-assisted laser desorption ionization-time of flight mass spectrometry 
(MALDI-TOF MS).   
Isolated red cell membranes were digested with 20 μg mL−1 α-Chy in 5P8 at 37 °C for 10 min.  
After centrifuging at 20,000 g, the supernatant was collected as the N-CPD-containing 
fraction for the mass spectrometric analysis.  The MSD of AE1 was separated according to 
the method of Abe et al.43  Red cell membranes were first treated with 1 μg mL−1 Try in 5 
mM NaHCO3 on ice for 30 min to remove N-CPD.  The trypsinized membranes were 
subsequently treated with 0.1 M NaOH for 30 min on ice and 25 μg mL−1 Try in 5P8 for 1 h at 
37 °C.  The resulting membranes were delipidated by a mixture of chloroform and methanol, 
and the deposited protein was dissolved in a 1 : 2 mixture by volume of acetonitrile and 
iso-propanol for the analysis. 
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Sample solutions were mixed with an equal volume of matrix solution [saturated 
sinapinic acid in 0.1 % trifluoroacetic acid (TFA) and 34 % acetonitrile for the N-CPD 
containing fraction, and in 0.1 % TFA and 50 % acetonitrile for the MSD-containing fraction], 
and an aliquot was applied on an AnchorChipTM target (Bruker Daltonics, Inc.) that was 
loaded with a sinapinic acid matrix thin layer.  Mass spectra were acquired in linear positive 
ion mode using an Ultraflex MALDI TOF/TOF mass spectrometer (Bruker Daltonics, Inc.).  
Spectra were calibrated with Protein Calibration Standard I (Bruker Daltonics, Inc.).  
Cys-containing fragments were identified by theoretical mass calculation using the protein 
prospector program (http://prospector.ucsf.edu/prospector/mshome) and chemical 
modification of cysteine residues by NEM. 
Reaction of Pen-SSeS-Pen with red cell membranes   
L-Penicillamine selenotrisulfide (Pen-SSeS-Pen) was synthesized from Pen and selenious acid 
according to a previously described procedure44,45: Elemental analysis (%), calculated for 
C10H20N2O4S2Se: C 31.97, H 5.33, N 7.46, Se 21.04; found: C 31.13, H 5.86, N 7.24, Se 21.89.  
MALDI-TOF MS, calculated for C10H20N2O4S280Se; 376.24, found: 376.83.  [α]D, +7.07.  
λmax in deionized water 266 nm (εmM: 1.47).  Isolated red cell membranes were incubated 
with 0.1 or 1 mM Pen-SSeS-Pen in 5P8 at 37 °C for 30 min.  Thiol contents of the red cell 
membranes and Pen-SSeS-Pen solution before and after the reaction were measured by the 
DTNB method.  Selenium binding sites analysis and MALDI-TOF MS were performed as 
mentioned above.  N-Ethylmaleimide (NEM) and iodoacetamide (IAA) used for thiol 
alkylation were from Nacalai Tesque, Inc.  The isolated red cell membranes were treated 
with 1 mM NEM and 1 mM IAA at 37 °C for 10 min.  Thiol content in the specimens was 
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spectrophotometrically determined using 5,5’-dithiobis (2-nitrobenzoic acid) (DTNB, Sigma 
Co., Ltd.).  The red cell membranes were suspended in 5P8 containing 1 % SDS and added 
to an equal volume of a 1 mM DTNB solution.  The absorbance at 450 nm was measured at 
1 h after incubation. 
Selenium export experiments from the resealed membranes   
Resealed red cell membranes were prepared from 8 μM SA-treated red cells according to the 
method of Steck and Kant.42  After hemolysis, unsealed membranes were suspended in 40 
volumes of phosphate-buffered saline (PBS) and incubated for 40 min at 37 °C to induce 
resealing.  The membranes were then pelleted by centrifugation and washed twice with PBS.  
The quality of the resealed membrane was estimated from the determination of 
NADH-cytochrome c oxidoreductase activity, which resides on the cytoplasmic surface of the 
membrane.  Briefly, the membranes were suspended in PBS with or without saponin, and 
then β-NADH and cytochrome c were sequentially added.  The reaction was monitored at 
550 nm for 10 min.  The resealed membrane purity was calculated using the following 
equation (Δ Asaponin (−) / Δ Asaponin (+)) × 100 (%), where ΔAsaponin (−) and Δ Asaponin (+), respectively, are 
the changes in absorbance at 550 nm of sample solutions between 0 and 10 min after addition 
of the substrate in the absence and presence of saponin.  The quality of the resealed 
membrane was estimated to be 91.7 ± 1.0 % throughout the selenium export experiments. The 
selenium-bound resealed membrane suspension (protein concentration 343.6 ± 2.4 μg mL−1) 
was then incubated with an equal volume of the plasma at 37 °C in a water bath with shaking 
at 60 strokes min−1.  Aliquots were withdrawn from the mixture at the indicated time 
intervals.  After centrifugation at 20,000 g for 20 min at 4 °C to separate the membranes and 
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the plasma, the selenium contents in the four fractions were determined.   
Statistical analysis   
All data were presented as the mean and standard error of the mean (SEM) (n = 6).  
Statistical analyses were performed using PRISM4 (GraphPad Software, Inc.).  The multiple 
mean values were compared by a two-way analysis of variance with a Bonferroni posthoc test.  
Comparisons were considered statistically significant at P < 0.05. 
Results 
Selenium export from red cells to the plasma   
The selenium export from the SA-treated red cells to the plasma was examined under various 
conditions.  When the SA-treated red cells were incubated in the plasma at 37 °C (the 
control conditions), the selenium content in the red cells gradually decreased over 60 min, 
meanwhile, that in the plasma increased in an inverse manner (Fig. 1 a).  No selenium export 
from the SA-treated red cells occurred when using isotonic buffer solutions instead of the 
plasma at 37 °C.  The selenium species that once appeared in the plasma did not return to the 
red cells.  Such a selenium export process was not suppressed by treatment of the red cells 
with 4,4’-diisothiocyanato-2,2’-stilbene disulfonate (DIDS), a specific AE1 inhibitor, at a 
concentration at which its anion exchange function is almost completely blocked (Fig. 1 b).46  
To the contrary, incubation of the SA-treated red cells at 4 °C blocked the selenium export to 
the plasma in which the AE1 is active in the anion exchange function (Fig. 1 c).  The 
selenium export activity was also inhibited by the pre-incubation in the isotonic phosphate 
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buffer (pH 7.4) for 2 h, which results in ATP-depletion in red cells (Fig. 1 d) but was 
maintained by the addition of adenosine 5’-triphosphate (ATP) source materials (5 mM 
glucose, 10 mM inosine and 2 mM adenine sulfate) to the buffer solution during the 
pre-incubation.47   
Analysis of selenium species in red cell membranes   
To explore the selenium binding to the AE1 protein, red cell membranes isolated from the 
SA-treated red cells were electrophoresed on sodium dodecyl sulfate-polyacrylamide gels, 
and then the selenium contents of the protein bands were analyzed by the DAN method 
subsequent to acid digestion.  Nearly half of the total selenium in the membranes was found 
in band 3, while the rest was in bands 1 and 2 that are assigned to spectrins (Fig. 2 a).  The 
red cell membranes were fractionated into four fractions (N-CPD-, peripherals-, C-CPD- and 
MSD-containing fractions) by enzymatic digestions and alkaline treatment, and their selenium 
contents were determined by the DAN method subsequent to acid digestion (Fig. 2 b).  The 
selenium was detected in fractions (i), (iii) and (iv) which, respectively, contain the three 
domains of AE1: 42.7 ± 1.2 % in the N-CPD-containing fraction, 7.8 ± 0.8 % in the 
C-CPD-containing fraction and 21.0 ± 1.7 % in the MSD-containing fraction.   
Because most selenium (> 98 %) in the SA-treated red cells is bound to the Cysβ93 of 
Hb39, the Hb β chain was initially analyzed by MALDI TOF mass spectrometry.  The Hb β 
chain from the SA-treated red cells gave a peak at 16.254 × 103 m/z (Fig. 2 c-2), resulting in 
an increase in m/z by 0.386 × 103 in comparison to that from the non-treated one (Fig. 2 c-1).  
Such an increase in the molecular mass of the Hb β chain corresponded to the 
selenenyl-glutathione (SeS-G) moiety, demonstrating the formation of Hb-Cysβ93-SSeS-G 
 13 
species.  Treatment of the red cell membranes with dithiothreitol, which reductively cleaves 
disulfide and trisulfide bonds, almost quantitatively eliminated the selenium bound to the 
membranes, thus indicating that the thiols of the membranes participated in the selenium 
binding.  A Cys317-containing fragment of the N-CPD without the SA treatment was 
detected at 3.635 × 103 m/z (Fig. 2 d-1), which was identified by theoretical mass calculation 
using the protein prospector program and the molecular mass gain in m/z by 0.125 × 103 after 
alkylation with NEM (Fig. 2 d-2).  The membrane sample from the SA-treated red cells 
provided a peak at 4.021 × 103 m/z, resulting in an increase in m/z by 0.380 × 103 in 
comparison to that from the non-treated ones (Fig. 2 d-3).  The observed increase in the 
molecular mass of the Cys317-containing fragment corresponded to the SeS-G moiety, similar 
to that for the Cysβ93 of Hb.   
Reactivity of AE1 thiols with selenotrisulfide   
The reactivity of the AE1 thiols with selenotrisulfide was investigated using Pen-SSeS-Pen as 
a small-molecule probe (Fig. 3 a).  The Pen-SSeS-Pen could be reactive with thiols of not 
only peripheral proteins but also integral ones, because of its membrane-penetrating character.  
After the reaction of unsealed red cell membranes with Pen-SSeS-Pen, the membranes were 
separated into the four fractions (N-CPD, peripherals, C-CPD and MSD), and their selenium 
contents were determined.  The N-CPD-, the MSD- and the C-CPD-containing fractions 
respectively contained 48.3 ± 3.5, 12.4 ± 1.5 and 5.1 ± 0.8 % of selenium in the membranes 
(Fig. 3 b).  In the comparison to the SA-treated membranes (Fig. 2 b), similar trends of the 
selenium binding were found for the N-CPD- and the C-CPD-containing fractions, but the 
binding rate to the MSD-containing fraction decreased.   
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To examine the mode of the reaction between the AE1 thiols and Pen-SSeS-Pen, thiol 
contents of the membranes and the mixture before and after the reaction were determined by 
the DTNB method.  The thiol content of the membranes after the reaction decreased to 60.8 
± 1.0 %, whereas the thiol content of the mixture was 98.8 ± 2.0 % of that from the added 
membranes.  Thus, overall oxidation-reduction events did not entirely occur in the reaction 
of Pen-SSeS-Pen with the membrane, and thiols corresponding to the 40 % decrease in the 
membrane thiols were generated outside the membranes by the reaction.   
In MALDI TOF spectrometric analysis, a Cys317-containing fragment from the 
Pen-SSeS-Pen-treated membrane gave a peak at 3.863 × 103 m/z (Fig. 3 c-3), resulting in an 
increase in m/z by 0.226 × 103 in comparison to the non-treated one (Fig. 3 c-1).  Such an 
increase in the molecular mass corresponded to that of the selenenyl-penicillamine (SeS-Pen) 
moiety, indicating that Pen-SSeS-Pen can be reacted with Cys317 through thiol exchange to 
form selenotrisulfide (N-CPD-Cys317-SH + Pen-SSeS-Pen → N-CPD-Cys317-SSeS-Pen + 
Pen-SH).  A SeS-Pen-adduct peak at 6.183 × 103 m/z (Fig. 3 e-1) was detected for a 
Cys843-containing fragment of the MSD (Fig. 3 e-1), whereas no similar adduct peak was for 
a Cys479-containing fragment of the MSD (Fig. 3 d-1 and d-3).   
Effects of thiol modification on the selenium binding to MSD   
The reaction manner between selenotrisulfide and the AE1 thiols was further examined using 
the membranes that were chemically modified with thiol-alkylating agents, NEM and IAA.  
Under the conditions used in this study, the NEM treatment alkylated ≈ 50 % of the thiols of 
the N-CPD, but none of the MSD and the C-CPD.  While the IAA treatment modified ≈ 
80 % of the thiols of the N-CPD, ≈ 30 % of the MSD and ≈ 40 % of the C-CPD (Fig. 4 a−c).  
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These thiol-modified membranes were incubated with Pen-SSeS-Pen, and their selenium 
contents of the MSD fraction were compared to that of the non-treated one.  The selenium 
content of the MSD in the NEM-treated membranes decreased to less than half of that of the 
non-treated ones, even though its thiols were not modified at all.  Likewise, for the 
IAA-treated membranes, the selenium from Pen-SSeS-Pen did not bind to the MSD, although 
≈ 70 % of the thiols of the MSD were in the free form (Fig. 4 d), and the unsealed membranes 
could be reacted with the Pen-SSeS-Pen on both their cyto- and exoplasmic faces.   
Export of the membrane-bound selenium to the plasma   
To investigate the selenium transport manner in the red cell membranes, the resealed 
membranes from the SA-treated red cells were incubated in the plasma, and the selenium 
contents of the four membrane fractions were determined at the indicated time interval (Fig. 
5).  The selenium bound to the resealed membranes were gradually exported to the plasma 
and decreased to ≈ 40 % of that initially bound at 60 min after incubation.  The selenium 
content of the N-CPD- and the MSD-containing fractions [fractions (i) and (iv) in Fig. 5] 
markedly decreased, while those of the peripherals- and the C-CPD-containing fractions 
showed little change.  Thus, the selenium bound to the N-CPD and the MSD of the AE1 in 
the resealed membranes was preferentially exported to the plasma.   
Discussion 
The selenium export from the red cells to the plasma was distinct from the anion exchange 
process of the AE1 from the following viewpoints; (a) a kinetically slower process (cf. anion 
 16 
exchange turnover rate of 5 × 104 anions s−1 48), (2) no inhibition by treatment with a typical 
AE1 inhibitor DIDS, (c) complete export inhibition by 4 °C operation, and (d) export 
inhibition under an ATP depletion condition (Fig. 1).  The selenium export from the 
SA-treated red cells involved an ATP-dependent mechanism.  This export process did not 
occur in plain isotonic buffer solutions and required thiols in the outer medium.49  In addition, 
when an isotonic penicillamine solution instead of the plasma was used in the selenium export 
experiment, the selenium species exported was found in the chemical form of 
Pen-SSeS-Pen.49  Separately, we reported that the chemical modification of thiols of red cell 
membranes results in complete inhibition of the selenium export from the red cells to the 
plasma.40  Biogenic thiols in the bloodstream, such as Hb and glutathione in red cells and 
albumin in the plasma, can participate in the metabolism and/or transport of selenium species 
inside the red cells and the subsequent transport to the peripherals.39,45,49  The thiols of 
spectrins can be interactive with glutathione to form disulfide bond, which associates to the 
flexible deformation of red cells in the peripheral capillaries.50  Thus, spectrin thiols could 
possibly interact with selenium metabolites, and the selenium binding to spectrins was 
actually observed (Fig. 2a).  In our previous study using red cell inside-out vesicles, we 
demonstrated that selenium bound to Hb in the red cells is not transported to the 
N-CPD-deleted red cell membrane at all.39  The vast majority of selenium (> 98 % of the 
total amount) in the SA-treated red cells is bound to Hb.39  The selenium transport from Hb 
to the N-CPD of AE1 was thought to be the prerequisite event for the subsequent membrane 
transport of selenium to the plasma.  Thus, the scaffold protein spectrins are unlikely to 
directly transport out selenium to the plasma.  The selenium bound to spectrins probably 
comes from the interaction with low-mass selenium species, such as G-SSeS-G.  The thiols 
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of the integral protein AE1 were likely to play a role in the selenium transport across the red 
cell membrane.  Taking these features together, the selenium export from the red cells to the 
plasma was thought to involve a function of the AE1 that is mediated by its thiols, not the 
already known the anion exchange function.   
A large fraction of selenium in the membranes from the SA-treated red cells was bound 
to the N-CPD, the C-CPD and the MSD (Fig. 2 a and b), which supported participation of the 
AE1 in the membrane transport of selenium.  MALDI TOF mass spectrometric detection of 
Hb-Cysβ93-SSeS-G and N-CPD-Cys317-SSeS-G in the SA-treated red cells (Fig. 2 c-2 and 
d-3 demonstrated that the membrane transport of selenium could proceed in the form of 
selenotrisulfide.  Therefore, these mass spectrometric data also implicated that selenium 
from the Hb-Cysβ93-SSeS-G is transported to the Cys317 on the basis of the intrinsic 
interaction of Hb with the N-CPD (N-CPD-Cys317-SH + Hb-Cysβ93-SSeS-G → 
N-CPD-Cys317-SSeS-G + Hb-Cysβ93-SH).  The selenium bound to the Hb seemed to be 
transported to the N-CPD of the AE1 in a manner similar to the NO bioactivity export from 
red cells (Hb-Cysβ93-SNO + N-CPD-Cys-SH → Hb-Cysβ93-SH + N-CPD-Cys-SNO).36 33   
On the basis of the mass spectrometric analysis of the SA-treated red cell membranes 
and Hb, selenotrisulfide was thought to be the structural moiety to be transferred during the 
membrane transport of selenium.  Thus, the reactivity of the AE1 thiols with selenotrisulfide 
was investigated using Pen-SSeS-Pen.  Pen-SSeS-Pen itself is chemically stable under 
physiological conditions and is reactive with various thiols.  Thiol exchange between 
selenotrisulfide and thiol is a reversible reaction and proceeds without changing the thiol 
content in the reaction mixture [R-SSeS-R + 2 R’-SH ↔ (R-SSeS-R’ + R-SH + R’-SH) ↔ 
R’-SSeS-R’ + 2 R-SH].  Such a thiol exchange mechanism can provide a possible 
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explanation for the reaction of Pen-SSeS-Pen with the unsealed red cell membranes, and the 
selenium from Pen-SSeS-Pen was bound to the membrane in the form of selenotrisulfide via 
thiols of the membranes.  In fact, MALDI-TOF mass spectrometry independently confirmed 
that the selenotrisulfide adduct of the Cys317-containing fragment 
(N-CPD-Cys317-SSeS-Pen) was generated from the reaction of Pen-SSeS-Pen with the 
unsealed red cell membranes, as observed for the SA-treated membranes.  A similar adduct 
of the Cys843-containing fragment demonstrated that selenotrisulfide could possibly be 
reacted with this thiol through thiol exchange.  In aqueous media, thiol reagents can react 
with ionized thiol groups (R-S−) about 5 × 109-fold faster than with un-ionized ones (R-SH).51  
A thiol on the membrane lipid-accessible surface will be less reactive, because its ionization is 
suppressed due to the low dielectric constant of the environment.52  Thus, thiols in the 
membrane lipid-accessible surface will be much less reactive with thiol reagents than those in 
the water-accessible surface.  Actually, the thiols of the MSD in both the NEM- and the 
IAA-treated red cell membranes remained in part to be modified.  Because the AE1 is 
reported to undergo palmitoylation through the thiol of the Cys843 of the MSD,53 and this 
thiol also allowed alkylating with NEM (Fig. 3 e-2), the thiol of the Cys843 could possibly 
provide a reaction site for selenotrisulfide.  On the other hand, the other Cys residue of the 
MSD (Cys479) was unlikely to be reactive with selenotrisulfide.   
The selenium from Pen-SSeS-Pen (Fig. 3 b) was less transferrable to the MSD in 
comparison to that from the Hb-Cysβ93-SSe-G (Fig. 2 b).  When NEM and IAA 
incompletely modified the thiols of the MSD, the proportion of selenium bound to the MSD 
was not entirely dependent on their thiol contents (Fig. 4 d).  Thus, the selenium binding to 
the MSD was thought to be not due to the direct thiol exchange between Hb-Cysβ93-SSe-G 
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and the thiols of the MSD.  In addition, when used the isotonic phosphate buffer containing 
penicillamine instead of the plasma in the selenium export experiment, the selenium species 
exported was found in the chemical form of selenotrisulfide.41  These results suggested a 
relay mechanism for the selenium transport from the N-CPD to the MSD in the AE1 protein.  
To verify such a relay mechanism of the AE1 in the membrane transport of selenium, the 
selenium export from the resealed membranes from the SA-treated red cells to the plasma was 
examined.  The exported selenium to the plasma was dominantly attributed to that of N-CPD 
and MSD (Fig. 5), which suggested that thiols of N-CPD and MSD in AE1 serve as relay 
points in the membrane transport of selenium.  On the other hand, the selenium bound to 
C-CPD and the peripherals did not appear to be concerned with the selenium export to the 
plasma.  The selenium bound to the Cys317 of N-CPD seems to be intra- and/or 
intermolecularly relayed to the thiols of Cys843 of MSD and is subsequently exported to the 
plasma.  The thiol of Cys479 on a lipid-accessible surface may not be involved as a relay 
site of selenium to be exported from the thiols of N-CPD to the plasma, because this thiol was 
much less reactive with selenotrisulfide and other thiol-reactive reagents than that of Cys843.  
Taking these features together, the AE1 thiol-mediated selenium transport across the 
membrane was thought to involve a relay mechanism of thiol exchange; Hb-Cysβ93-SSeS-G 
+ N-CPD-Cys317-SH → Hb-Cysβ93-SH + N-CPD-Cys317-SSeS-G + MSD-Cys843-SH 
→ N-CPD-Cys317-SH + MSD-Cys843-SSeS-G + HSA-Cys34-SH → MSD-Cys843-SH + 
HSA-Cys34-SSeS-G (Fig. 6).   
Conclusions 
In conclusion, the erythroid integral protein AE1 mediated the membrane transport of 
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selenium from the red cells to the plasma in a thiol-dependent manner that is distinct from the 
already known anion exchange function.  In this pathway, thiol-reactive substances bound to 
the Hb-Cysβ93 such as selenium can be transported by the relay mechanism to thiols of the 
N-CPD of the AE1 on the basis of the intrinsic interaction between the two proteins and then 
subsequently exported to the plasma via the thiols of MSD.  This membrane transport 
mechanism would function in the export processes of NO vasodilator activity and other 
substances bound to the Hb-Cysβ93 from red cells to the plasma and/or peripherals.  The 
selenium export from the red cells to the plasma was also an energy-dependent process.   
 21 
References 
 1 M. P. Rayman, Lancet, 2000, 356, 233–241. 
 2 G. V. Kryukov, S. Castellano, S. V. Novoselov, A. V. Lobanov, O. Zehtab, R. Guigó and V. N. 
Gladyshev, Science, 2003, 300, 1439–1443. 
 3 L. Flohe, W. A. Günzler and H. H. Schock, FEBS Lett., 1973, 32, 132-134. 
 4 Y. Saito and K. Takahashi, Eur. J. Biochem., 2002, 269, 5746–5751. 
 5 L. Schomburg, U. Schweizer, B. Holtmann, L. Flohó, M. Sendtner and J. Köhle, Biochem. J., 2003, 
370, 397–402. 
 6 R. F. Burk, K. E. Hill, G. E. Olson, E. J. Weeber, A. K. Motley, V. P. Winfrey and L. M. Austin, J. 
Neurosci., 2007, 27, 6207–6211. 
 7 G. E. Olson, V. P. Winfrey, S. K. Nagdas, K. E. Hill and R. F. Burk, J. Biol. Chem., 2007, 282, 
12290–12297. 
 8 R. F. Burk and K. E. Hill, Annu. Rev. Nutr., 2005, 25, 215–235. 
 9 X. Chen, G. Yang, J. Chen, X. Chen, Z. Wen and K. Ge, Biol. Trace Elem. Res., 1980, 2, 91−107. 
10 L. Liang, S. Mo, P. Zhang, Y. Cai, S. Moua, G. Jiang and M. Wen, J. Chromatogr. A, 2006, 1118, 
139–143. 
11 H. Li, Y. Luo, Z. Li, L. Yang and Q. Wang, Anal. Chem., 2012, 84, 2974－2981. 
12 P. V. Dael, L. Davidsson, R. Muñoz-Box, L. B. Fay and D. Barclay, Br. J. Nutr., 2001, 85, 
157−163. 
13 J. D. Carver, Am. J. Clin. Nutr., 2003, 77, 1550S−1554S. 
14 T. K. Suzuki, Y. Shiobara, M. Itoh and M. Ohmichi, Analyst, 1998, 123, 63−67. 
15 A. Mas, J. Jiang and B. Sarkar, Biol. Trace Elem. Res., 1988, 15, 97–110. 
16 K. T. Suzuki and M. Itoh, J. Chromatogr. B, 1997, 692, 15–22. 
17 Y. Shiobara and K. T. Suzuki, J. Chromatogr. B, 1998, 710, 49–56. 
18 G. Fairbanks, T. L. Steck and D. F. H. Wallach, Biochemistry, 1971, 10, 2606−2617. 
19 R. R. Kopito and H. F. Lodish, Nature, 1985, 316, 234−238. 
20 M. J. A. Tanner, P. G. Martin and S. High, Biochem. J., 1988, 256, 703−712. 
21 S. E. Lux, K. M. John, R. R. Kopito and H. F. Lodish, Proc. Natl. Acad. Sci. U.S.A., 1989, 86, 
9089−9093. 
22 L. J. Bruce, R. Beckmann, M. L. Ribeiro, L. L. Peters, J. A. Chasis, J. Delaunay, N. Mohandas, D. J. 
Anstee and M. J. A. Tanner, Blood, 2003, 101, 4180−4188. 
23 D. Sterling, R. A. F. Reithmeier and J. R. Casey, J. Biol. Chem., 2001, 276, 47886−47894. 
24 S. L. Alper, Exp Physiol., 2005, 91, 153−161. 
 22 
25 P. S. Low, Biochim. Biophys. Acta, 1986, 864, 145−167. 
26 J. A. Walder, R. Chatterjee, T. L. Steck, P. S. Low, G. F. Mussofg, E. T. Kaiser, P. H. Rogers and A. 
Amone, J. Biol. Chem., 1984, 259, 10238−10246. 
27 S. H. Chang and P. S. Low, J. Biol. Chem., 2003, 278, 6879−6884. 
28 V. Bennett and P. J. Stenbuck, J. Biol. Chem., 1980, 255, 6424−6432. 
29 A. C. Rybicki, R. S. Schwartz, E. J. Hustedt and C. E. Cobb, Blood, 1996, 88, 2745−2753. 
30 R. G. Langdon and V. P. Holman, Biochim. Biophys. Acta, 1988, 945, 23−32. 
31 S. L. Alper, Exp. Physiol., 2006, 91, 153−161. 
32 J. R. Casey, Y. Ding and R. R. Kopito, J. Biol. Chem., 1995, 270, 8521−8527. 
33 S. Grinstein, S. Ship and A. Rothstein, Biochim. Biophys. Acta, 1978, 507, 294−304. 
34 S. Lepke, A. Becker and H. Passow, Biochim. Biophys. Acta, 1992, 1106, 13−16. 
35 J. M. Sayare and M. Fikiet, J. Biol. Chem., 1981, 256, 13152−13158. 
36 J. R. Pawloski, D. R. Hess and J. S. Stamler, Nature, 2001, 409, 622−626. 
37 T. J. McMahon, R. E. Moon, B. P. Luschinger, M. S. Carraway, A. E. Stone, B. W. Stolp, A. J. Gow, 
J. R. Pawloski, P. Watke, D. J. Singel, C. A. Piantadosi and J. S. Stamler, Nat. Med., 2002, 8, 
711−717. 
38 K. N. Houk, B. N. Hietbrink, M. D. Bartberger, P. R. McCarren, B. Y. Choi, R. D. Voyksner, J. S. 
Stamler and E. J. Toone, J. Am. Chem. Soc., 2003, 125, 6972−6976. 
39 M. Haratake, K. Fujimoto, R. Hirakawa, M. Ono and M. Nakayama, J. Biol. Inorg. Chem., 2008, 
13, 471−479. 
40 M. Haratake, M. Hongoh, M. Ono, and M. Nakayama, Inorg. Chem., 2009, 48, 7805−7811. 
41 J. Watkinson, Anal. Chem., 1966, 38, 92−97. 
42 T. L. Steck and J. A. Kant, Methods Enzymol., 1974, 31, 173−180. 
43 Y. Abe, T. Hamasaki, S. Turusaki, S. Takazakia, X. Jina, D. Kanga and N. Hamasaki, Protein Pept. 
Lett., 2006, 13, 761−767. 
44 M. Haratake, M. Ono and M. Nakayama, J. Health Sci., 2004, 50, 366−371. 
45 M. Haratake, K. Fujimoto, M. Ono and M. Nakayama, Biochim. Biophys. Acta, 2005, 1723, 
215−220. 
46 J. J. Falke and S. I. Chan, Biochemistry, 1986, 25, 7895−7898. 
47 C. J. Feo and P. F. Leblond, Blood, 1974, 44, 639−647. 
48 J. Brahm, J. Gen. Physiol., 1977, 77, 283−306. 
49 M. Haratake, M. Hongoh, M. Miyauchi, R. Hirakawa, M. Ono and M. Nakayama, Inorg. Chem., 
2008, 47, 6273−6280. 
50 C. P. Johnson, H.-Y. Tang, C. Carag, D. W. Speicher and D. E. Discher, Science, 2007, 317, 
663–666. 
 23 
51 D. D. Roberts, S. D. Lewis, D. P. Ballou, S. T. Olson and J. A. Shafer, Biochemistry, 1986, 25, 
5595−5601. 
52 A. Karlin and M. H. Akabas, Methods Enzymol., 1998, 293, 123−145. 
53 K. Okubo, N. Hamasaki, K. Hara and M. Kageura, J. Biol. Chem., 1991, 266, 16420−16424. 
 24 
    
    
Fig. 1. Selenium export from red cells to the plasma.  Red cells were treated with 8 μM SA 
and then incubated in the plasma under various conditions: (a) incubated in the plasma at 37 
ºC (control), (b) treated with 50 μM DIDS at 37 ºC for 10 min 37 ºC prior to combine with the 
plasma, (c) incubation in the plasma at 4 ºC, (d) incubated in the isotonic phosphate buffer 
(pH 7.4) for 2 h prior to combine with the plasma at 37 ºC.  ATP concentrations in red cells 
before and after incubation were 1.31 and 0.22 μM mL−1-red cell, respectively.  The 
selenium amounts in the red cells at time 0 were defined as 100 %.  Solid circle, selenium 


























































































































      
    
Fig. 2. Analysis of red cell membranes after treatment of SA.  (a) SDS-PAGE of the 
membranes and its western blotting using anti-AE1 antibody and measurements of selenium 
contents of the protein bands.  n. d., not detected.  (b) Selenium distribution in the 
membranes: fraction (i), % released from the α-Chy digestion; (ii), % released from the 
NaOH extraction, (iii), % released from the Try digestion; (iv), % remaining in the membrane 
after Try digestion.  Red cells were treated with 8 μM SA and osmotically hemolyzed.  
After thoroughly washing, the obtained red cell membranes were sequentially treated with 0.2 
mg mL−1 α-Chy for 10 min, 0.1 M NaOH for 30 min on ice and 25 μg mL−1 Try for 1 h at 
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0.097 ± 0.006 ng mg−1-protein and defined as 100 %.  (c-1) and (c-2) MALDI TOF mass 
spectra of Hb β chain: (c-1) treated without SA (calcd molecular mass 15.851 × 103), (c-2) 
treated with 8 μM SA.  (d-1)−(d-3) MALDI-TOF MS spectra of Cys317-containing 
fragment of N-CPD (Asp316−Tyr347, calcd molecular mass 3.637 × 103):  (d-1), treated 
without SA; (d-2) treated with 1 mM NEM; (d-3), treated with 8 μM SA.  Unsealed 
membranes from red cells treated without and with 8 μM SA were digested with 20 μg mL−1 
α-Chy in 5P8 at 37 °C for 10 min.  After centrifugation at 20,000 g, supernatant was used 




       



















































































































      
Fig. 3. Analysis of red cell membranes after treatment of Pen-SSeS-Pen.  (a) Chemical 
structure of Pen-SSeS-Pen, (b) Selenium distribution in red cell membranes: fraction (i), % 
released from the α-Chy digestion; (ii), % released from the NaOH extraction; (iii), % 
released from the Try digestion; (iv), % remaining in the membrane after the Try digestion.  
Unsealed red cell membranes were treated with 1 mM Pen-SSeS-Pen for 10 min in the 
isotonic phosphate buffer (pH 7.4).  After thoroughly washing, the resulting membranes 
were sequentially treated with 0.2 mg mL−1 α-Chy for 10 min, 0.1 M NaOH for 30 min on ice 
and 25 μg mL−1 Try for 1 h at 37 °C.  The selenium content of the red cell membranes after 
the treatment of Pen-SSeS-Pen was 0.78 ± 0.03 ng mg−1-protein and defined as 100 %.  
(c-1)−(c-3) MALDI-TOF mass spectra of Cys317-containing fragments (Asp316−Tyr347, 
calcd molecular mass 3.637 × 103).  (d-1)−(d-3) MALDI-TOF mass spectra of 
Cys479-containing fragments (Asn433−Lys551, calcd molecular mass 13.504 × 103).  
(e-1)−(e-3) MALDI-TOF mass spectra of Cys843-containing fragments (Val828−Arg879, 
calcd molecular mass 5.956 × 103).  (c-1), (d-1) and (e-1), without treatment; (c-2), (d-2) and 
(e-2), treated with 1 mM NEM; (c-3), (d-3) and (e-3), treated with 0.1 mM Pen-SSeS-Pen.  
Unsealed membranes were treated with 0.1 M NaOH and then allowed to react with 0.1 mM 
Pen-SSeS-Pen.  Cys317-containing fragment of the N-CPD was collected by 20 μg mL−1 
α-Chy digestion in 5P8 at 37 °C for 10 min.  After centrifugation at 20,000 g, supernatant 
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Fig. 4. Thiol and selenium contents of red cell membranes.  (a)−(c) thiol contents of the 
N-CPD, MSD and C-CPD. (d) selenium content of the MSD after treatment with 
Pen-SSeS-Pen.  Unsealed membranes were treated with 1 mM NEM and 1 mM IAA at 
37 °C for 10 min, and then with 0.1 mM Pen-SSeS-Pen in 5P8. *P < 0.05, significantly 
different from the ghost sample by a two-way analysis of variance. 
 31 
 
Fig. 5. Selenium export from resealed membranes to the plasma.  Fraction (i), from the 
α-Chy digestion: (ii), from the NaOH extraction, (iii), from the Try digestion: (iv), remaining 
in the membrane after the Try digestion.  Resealed membranes from red cells treated with 8 
μM SA were incubated in the plasma.  The membranes were fractionated according to the 
procedure described in Methods section, and the selenium content in the each fraction was 
determined by the DAN method subsequent to acid-digestion.  The selenium content of the 
red cell membranes before mixing with the plasma (at incubation time 0) was the same as that 







Fig. 6. A proposed mechanism of AE1 thiol-mediated membrane transport of selenium from 
red cells to the plasma.   
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Graphical abstract for the contents entry page 
 
We demonstrate that the erythroid anion exchanger 1 membrane protein (AE1) mediates the 
membrane transport of selenium, an essential antioxidant micronutrient, from red cells to the 
plasma in a thiol-mediated and energy-dependent manner that is distinct from the already 
known anion exchange function.  In this pathway, selenium bound to the cysteine 93 of the 
hemoglobin β chain (Hb-Cysβ93) is transported by a relay mechanism to the Cys317 of the 
amino-terminal cytoplasmic domain of the AE1 on the basis of the intrinsic interaction 
between the two proteins and is subsequently exported to the plasma via the Cys843 of the 
membrane-spanning domain.   
 
 
